Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 8 February 2021 Read more about Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 8 February 2021
Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study Read more about Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study
Bone Therapeutics and Rigenerand sign partnership for cell therapy process development Read more about Bone Therapeutics and Rigenerand sign partnership for cell therapy process development
Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook Read more about Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook
Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 26 February 2021 Read more about Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 26 February 2021
Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference Read more about Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference
Bone Therapeutics appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scientific Officer Read more about Bone Therapeutics appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scientific Officer
Bone Therapeutics announces 2020 full year results Read more about Bone Therapeutics announces 2020 full year results
Bone Therapeutics to host Annual General Meeting on 9 June 2021 Read more about Bone Therapeutics to host Annual General Meeting on 9 June 2021